• careers
  • sitemap
  • contact

AdvaxisAdvaxis - Technology in Immunoterapy

  • Company
    • Overview
    • Management
    • Board of Directors
    • Scientific Advisory Board
  • Technology
    • Why Listeria
    • How Advaxis Uses Listeria
    • Common Concerns
    • Intellectual Property
    • Bibliography
    • Vaccine Congress Presentation
  • Clinical Development
    • Lovaxin C
    • Lovaxin B
    • Lovaxin P
    • Lovaxin SCCE
  • Investors
    • Overview
    • Fact Sheet
    • Company PowerPoint
    • Webcasts
  • News
    • 2008 Press releases
    • 2007 Press releases
    • 2006 Press releases
    • 2005 Press releases
    • 2004 Press releases
    • 2003 Press releases
    • 2002 Press releases

Archives

  • 2008 Press Releases
  • 2007 Press Releases
  • 2006 Press Releases
  • 2005 Press Releases
  • 2004 Press Releases
  • 2003 Press Releases
  • 2002 Press Releases

News

2004 Press Releases

November 12, 2004
Great Expectations and Associates, Inc. Acquires Advaxis, Inc. and Successfully Completes $3,520,000 Equity Financing Friday November 12, 1:15 pm ET

August 25, 2004
Advaxis, INC. Signs share exchange and reorganization agreement with Great Expectations and Associates, Inc.

May 17, 2004
Advaxis, Inc Receives a $600,000 SBIR Grant For The Development of a Novel Bacterial Therapeutic Vaccine for Cervical Cancer

April 19, 2004
Advaxis, Inc Receives $200,000 SBIR Grant For The Development of a Novel Protein Therapeutic Vaccine for Cervical Cancer

Home

Copyright © 2008 - Advaxis Inc. - All rights reserved